Drug profile · INN
apadamtase alfa / cinaxadamtase alfa
ADZYNMA
apadamtase alfa / cinaxadamtase alfa (ADZYNMA) is a a disintegrin and metalloproteinase with thrombospondin motifs 13 exogenous protein.
Drug details — apadamtase alfa / cinaxadamtase alfa
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
apadamtase alfa / cinaxadamtase alfa (ADZYNMA) is a a disintegrin and metalloproteinase with thrombospondin motifs 13 exogenous protein.
Key facts
Mechanism of action
A disintegrin and metalloproteinase with thrombospondin motifs 13 exogenous protein
Primary target: A disintegrin and metalloproteinase with thrombospondin motifs 13
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is apadamtase alfa / cinaxadamtase alfa?
apadamtase alfa / cinaxadamtase alfa (ADZYNMA) is a a disintegrin and metalloproteinase with thrombospondin motifs 13 exogenous protein.
What is the brand name for apadamtase alfa / cinaxadamtase alfa?
ADZYNMA is a marketed brand name for apadamtase alfa / cinaxadamtase alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.